SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cal Gary who wrote (8168)12/5/2001 10:22:56 PM
From: Montana Wildhack  Read Replies (1) of 14101
 
CG,

I'm not sure I agree on this:

"...despite some regulatory delays in
PENNSAID approval," said Rebecca Keeler" Psst, this is a hint. Negative.

The full context was:

"We are very pleased to have extended our agreement with Acqua Wellington
for an additional few months, through May, 2002, to continue the flexibility
to access funds as necessary, despite some regulatory delays in PENNSAID(R)
approval." said Rebecca Keeler, President and CEO. "The market into which
PENNSAID(R) will launch is large, at over $8 billion in NSAID sales annually
in the United States and Canada."

The phrase was specifically in context to extension.
Shortening the sentance to its basics gives you "we extended
the agreement despite some regulatory delays."

The next sentance says Pennsaid will be launched in the
US and Canadian markets. No qualifiers on that very clear
setting of shareholder expectation.

Wolf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News